Alpha Cognition Inc
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACOG and other ETFs, options, and stocks.About ACOG
Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. It has additional pre-clinical development programs: ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease, ALPHA-1062 sublingual formulation, ALPHA-1062 intranasal (“ALPHA-1062IN”) formulation for the treatment of cognitive impairment with mild traumatic brain injury (mTBI, otherwise known as concussion) and ALPHA-0602, ALPHA-0702 & ALPHA-0802.
ACOG Key Statistics
Stock Snapshot
As of today, Alpha Cognition Inc(ACOG) shares are valued at $7.90. The company's market cap stands at 171.8M, with a P/E ratio of -5.76.
On 2026-07-07, Alpha Cognition Inc(ACOG) stock traded between a low of $7.65 and a high of $8.41. Shares are currently priced at $7.90, which is +3.3% above the low and -6.1% below the high.
Alpha Cognition Inc(ACOG) shares are trading with a volume of 45.84K, against a daily average of 55.13K.
In the last year, Alpha Cognition Inc(ACOG) shares hit a 52-week high of $11.54 and a 52-week low of $4.50.
In the last year, Alpha Cognition Inc(ACOG) shares hit a 52-week high of $11.54 and a 52-week low of $4.50.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.